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Abstract: Despite on great success with artificial implant for human body, the modern 
implants could not solve major health problems. The reason is an immune reaction of 
organism on artificial implant known as foreign body reaction. We have found a way to 
avoid or decrease the foreign body reaction. The surface of artificial implant is modified 
with condensed aromatic structures containing free radicals, which provide a covalent 
attachment of host proteins in native conformation. The total protein coverage prevents 
direct contact of immune cells with the implant surface and the immune cells are not 
activated. As result the immune respond of organism is not generated and the artificial 
implant is not isolated from the tissue: no collagen capsule, low activity of macrophages, 
low cell proliferation, low inflammatory activity.  
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1. Introduction 
 
Modern artificial implants can successfully work in organisms for more then 20 years. It 
was estimated that only in USA 20 millions of people have a biomedical implants to save 
their life [1]. The success of the medical implant industry and surgery practice is proved by a 
high number of successful operations. However, the artificial implants are not complete 
solution. Research has shown that 73% of people who received artificial heart implants 
survived after 9 years and 65% survived after 18 years. In the case of artificial aorta implants 
85% of people survive after 5 years.  
The problem is a full integration of the implant into an organism. An intrusion of any 
artificial material into an organism causes a reaction of the organism’s immune system called 
Foreign Body Reaction or Foreign Body Respond (FBR) [2]. The immune reaction on the 
foreign body protects the organism against bacteria, viruses and injuries, and causes an 
isolation of the implant from the organism tissue that can break a functionality of the implant. 
In the worst case scenario the implant must be removed or replaced. This involves a 
secondary operation that increases the risk of lethality significantly, especially for elderly 
people who mostly need the implants. Research has shown that 100% of all artificial implants 
cause an immune reaction, and 35% of them require a secondary operation.  
The immune response on the artificial implant is manageable with immunodepressant 
therapy [1, 3, 4]. The immune system of entire organism is depressed to decrease or to avoid 
foreign body reaction on the implant. Such therapy is a common way to avoid the implant 
isolation. However, such depressed immune system cannot protect an organism against any 
disease. Most of such patient death is caused by another disease, not connected with implant 
itself.  
The Foreign Body Reaction is ignited by the implant surface interaction with host 
proteins (Figure 1) [5]. The protein molecules are adsorbed on the implant surface and the 
initial conformation of protein is damaged [6]. The immune cells recognize the protein with 
damaged conformation as a foreign protein and the immune cells are activated to destroy the 
protein. The cycle of attachment - damage conformation - destruction is repeated and 
repeated up to the immune cells activate next level of the immune respond such as neutrophil 
and macrophages collection near the implant surface, intensive cell proliferation and 
angiogenesis, collagen encapsulation and calcification (in worse case) of the collagen capsule 
to isolate the implant [6, 7]. The Foreign Body Reaction is detected by immune cell activity 
such as neutrophils and macrophages, intensive cell proliferation, inflammatory reaction, 
specific cytokines, and collagen capsule surrounding the implant.  
 
 
 
Figure 1. Scheme of foreign body reaction with main stages from the time of first contact of 
the implant with organism tissue. The scheme is adapted from literature data [5] for 
untreated polyurethane.  
 
The decrease of Foreign Body Reaction was observed earlier in our studies on ion beam 
implanted polyurethane implants in mice and rats [8]. The collagen capsule was not formed 
near the carbonized polyurethane surface even after 5 months in mice organism. The low 
immune respond was based on protein covalent attachment on the carbonized surface due to 
presence of free radicals at the edge of graphene sheets [9, 10]. However, the detailed 
histological investigation of the tissue surrounding the implant was not performed.  
In the present study we investigate the immune respond of organism on polyurethane 
implants treated by plasma immersion ion implantation (PIII) as a kind of general ion beam 
implantation method and describe a method to avoid the foreign body reaction for 
polyurethane implants without immunodepressant therapy.  
 
2. Materials and Methods  
Polyurethane (Figure 2) was synthesized from polypropylene glycol terminated by 
toluenediisocyanate (Aldrich) and polyoxitetramethylene (Aldrich) with a deficit of hydroxyl 
groups that gave 3D crosslinking of the macromolecules. The details of the synthesis are 
described in elsewhere [11]. The synthesized polyurethane was swollen in heptane to remove 
all non-crosslinked molecules and then dried on air up to complete evaporation of heptane 
controlled by FTIR spectra. The final films of 0.3 mm thickness and 150 mm diameter were 
used.  
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Figure 2. The general formula of PPG-DI-PTHF polyurethane. Crosslinking bonds are not 
shown.  
 
The polyurethane films were treated by Plasma Immersion Ion Implantation (PIII) by 20 
keV energy nitrogen ions of 40, 80, 200, 400 and 800 sec treatment time. The details of PIII 
treatment were described elsewhere [12]. Next day the films were cut to 3.5 diameter disks 
and implanted subcutaneously in mice. This experiment has been approved by the University 
of Sydney Animal Ethics Committee (protocol number K20/12-2011/3/5634) and conducted in 
accordance with the Australian Code of Practice for the Care and Use of Animals for 
Scientific Purpose. After 7 days the implants were taken from mice, sliced with microtome 
and investigated with Milligan’s trichrome, Hematoxylin-Eosin, F4-80, Ki-67 and Von 
Willebrand Factor staining following standard protocols [13]. The micro-photos were done 
with the Nikon microscope (Japan). The objectives x4 for low resolution image and x20 for 
high resolution image were used.  
Analysis of protein attachment on polyurethane surface was done with Bovine Serum 
Albumin (BSA) as an example. The polyurethane samples were incubated in BSA solution for 
24 hours at room temperature. Protein was diluted to 20 µg/ml in 10 mM sodium phosphate 
buffer pH 7. After incubation, the samples were regressively washed in the buffer and in 
deionized water. For covalently attached protein analysis, the polyurethane samples were 
washed in 2% sodium dodecyl sulphate (SDS) solution in deionised water at 700C 
temperature for 1 hour.  
FTIR ATR spectra in a range of 400-4000 cm-1 was recorded with the spectrometers 
Nicolet Magna 650 (USA), Digilab FTS (USA) and Excalibur (USA) were used. ATR spectra 
were recorded with ATR crystal Ge, the angle of the beam incident was 45 degrees, and 
number of scans was 100. The spectral resolution was 4 cm-1. A contact angle of deionized 
water and diiodomethane (Aldrich, Australia) on the polyurethane surface was measured 
with DS-10 device (KRUSS, Germany). Micro-Raman spectra were recorded in 1800 degree 
geometry excited by Nd:YAG laser line of secondary harmonic (532.14 nm wavelength) on a 
diffraction double monochromator HR800 (Jobin Yvon). The electron spin resonance spectra 
(ESR) were recorded using Adani electron spin resonance spectrometer (Minsk, Belarus). The 
surface topography of the polyurethane was measured with Atomic force microscopy (AFM) 
using Park System device (Park System, South Korea) in tapping mode with a speed of 1 Hz 
and amplitude 10 nm. Microphotos of the polyurethane surface were done with using of 
optical microscope MBS-10 attached video camera.  
 
3. Analysis of PIII treated polyurethane surface 
The untreated polyurethane surface is hydrophobic with water contact angle of 93 
degrees. The water drop measurements show significant decrease of the contact angle to 35-
45 degrees in 15 minutes after PIII treatment. The contact angle increases with the storage 
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time after PIII treatment up to 60-70 degrees. The angle is stabilised a week after PIII 
treatment. These changes were observed to be in a similar statistical range for all PIII 
treatment times from 40 sec to 800 sec. The contact angles of the water and diiodomethane 
were used for calculation of surface energy and its parts. The surface energy is an energetic 
parameter of the surface to describe an interaction with the adsorbed molecules. The surface 
energy increases from 33 mN/m for untreated polyurethane to 65-67 mN/m for freshly treated 
polyurethane. A week after PIII treatment the surface energy decreases with stabilisation at 
45-50 mN/m. The stabilized level of the surface energy is much higher then the surface energy 
of untreated polyurethane. The dispersic part of the surface energy increases from 31 mN/m 
for untreated polyurethane to 40-44 mN/m for freshly treated polyurethane and decreases 
with storage time up to 37-39 mN/m. The polar energy changes more dramatically. The polar 
part calculations show a value of 2 mN/m for untreated polyurethane. A short time after PIII 
treatment the polar part of surface energy increases to 17-27 mN/m and then decreases and is 
stabilised at 8-14 mN/m. Therefore, the surface is hydrophilic after PIII treatment.  
The Raman spectrum of PIII treated polyurethane (Figure 3a) contains new strong lines 
at 1348 and 1595 cm-1. These two lines are interpreted as resonance Raman lines of the 
carbonised top layer: D and G peaks. G-peak is E2g vibrations in graphitic structure with sp2 
hybridisation of the valence electrons. D-peak is A1g vibrations in graphitic structure. The 
ratio I(D)/I(G)=1.77 and G-peak position corresponds to I area in Robertson/Ferrari diagram 
[14] that shows a nanocrystalline graphite with characteristic size of graphitic islands of 
La=2.5 nm separated by amorphous carbon with sp3 hybridization.  
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Figure 3. (a) Micro-Raman spectra of 20 keV nitrogen ion PIII treated polyurethane at 800 sec 
(bottom spectrum). Two new strong peaks at 1348 and 1595 cm-1 show the presence of 
graphite planes with defects in PIII treated polyurethane. (b) Electron spin resonance spectra 
of untreated polyurethane (blue) and PIII treated polyurethane (red) recorded from the 
sample after 3 months storage in laboratory. Optical microphotos of polyurethane untreated 
(c) and after 800 sec PIII treatment by 20 keV energy nitrogen ions (d). The PU was 
synthesised and treated on silicone wafer to exclude any deformations after the treatment. 
Objective is x50. The developed surface structure with waves and cracks is observed after PIII 
treatment. AFM 3D 10x10 µm area image of the polyurethane surface untreated (e) and 
treated with PIII for 40 sec with 20 keV nitrogen ions (f).  
A signal of unpaired electrons in the modified polyurethane has detected with the 
electron spin resonance spectra. The electron spin resonance spectra of the untreated 
polyurethane and the PIII treated polyurethane at 800 seconds by nitrogen ions with 20 keV 
energy are presented in Figure 3b. The untreated polyurethane film does not have a signal 
higher than the noise level. The PIII treated film has a strong signal with g-factor about 
2.0028. The signal with such g-factor corresponds to unpaired electrons of carbon free radicals 
at the edges of aromatic structures in graphite- or graphene-like structures [15]. The spectra 
show that the free radicals in the modified layer appear after PIII treatment and then remain 
when it is stored for a further 3 months. Such long shelf-life free radicals are stabilised by π-
electrons of the aromatic rings of graphite-like structures.  
The surface topography of PPG-DI-PTHF-0.35 polyurethane was changed dramatically 
after PIII treatment that is visible with optical microscope and Atomic Force Microscope 
(Figures 3c-f). The treated surface is wrinkled and cracked. The direction of the wave and 
cracks are random. The surface topography remained stable after a month long storage time. 
The topography viewed was similar to polyurethane free standing films and polyurethane 
coating on hard substrate (silicon wafer). Therefore the surface wrinkles and cracks are not 
the result of a deformation of the sample. The surface topography corresponds to hard 
surface layer with internal stresses over the soft bulk layer.  
The Bovine serum albumin (BSA) has been used as an example in the attachment 
experiment. The polyurethane samples were incubated overnight in BSA solution in PBS 
buffer. The control samples were incubated in buffer solutions only. These were prepared the 
same way and at the same time as the protein attached samples. Then all samples were rinsed 
in deionized water and dried overnight, the FTIR ATR spectra was recorded. The spectral 
lines of protein are not visible in raw spectra of the samples as recorded due to high intensity 
of the polyurethane lines in comparison with the protein lines. The low intensity of protein 
lines corresponds to very thin BSA protein monolayer (about 5 nm) in comparison with the 
high intensity polyurethane spectrum. The spectra of control samples were subtracted from 
the spectra of protein samples treated at the same PIII treatment time with adjusted 
subtraction factor to minimise absorbance of polyurethane lines (Figure 4a). The subtracted 
spectra show Amide A line at 3300 cm-1, Amide I line at 1650 cm-1 and Amide II line at 1540 
cm-1. The line positions of Amide A and Amide II in the spectra of pure polyurethane and 
pure protein are similar. These lines in the subtracted spectra can be interpreted as related to 
both polyurethane and protein. Therefore these lines cannot be used for analysis of protein 
attachment. The Amide I line in the spectra of pure polyurethane was observed at 1720 cm-1, 
and the Amide I line in the spectra of pure protein was observed at 1650 cm-1. Due to these 
different positions, the Amide I line can be used for analysis of the protein attachment. The 
absorbance of Amide I line normalised on the line of polyurethane vibrations at 1100 cm-1 as a 
stable intensive line is presented in Figure 4b according to PIII treatment time. The amount of 
attached BSA increases with PIII treatment time up to saturation level. The saturation level 
observed after 800 seconds of PIII treatment time is double than for the untreated 
polyurethane.  
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Figure 4. (a) FTIR ATR spectra of attached BSA on untreated and PIII treated polyurethane of 
PPG-DI PTHF with 0.35 NCO/OH ratio. From bottom to top: (a) untreated polyurethane, (b) 
40, (c) 80, (d) 200, (e) 400, (f) 800 s PIII treatment time with 20 keV nitrogen ions. The spectra 
of corresponding polyurethanes are subtracted. (b) FTIR ATR spectra absorbance of Amide I 
line of BSA attached to polyurethane of PPG-DI PTHF with 0.35 NCO/OH ratio with PIII 
treatment time: blue is attached BSA, red is BSA attached and then washed off in SDS 1 hour 
at 700C. The absorbance of Amide I of protein was normalized on the absorbance of 1100 cm-
1 line related to vibrations in polyurethane.  
The detergent SDS was used for washing the non-covalently attached BSA molecules 
from the polyurethane surface. The experiment was done with the same samples of 
polyurethane after FTIR spectra recording. After washing in the detergent, all samples were 
rinsed in deionized water and dried overnight. The FTIR ATR spectra of control samples 
were subtracted from the spectra of protein samples as described above and absorbance of 
protein Amide I line was calculated and presented in Figure 4b. The protein lines in the 
spectrum of untreated polyurethane are not observed, and are under the noise level of the 
spectrum. The spectra of SDS washed samples show the Amide I line of the attached protein 
only for PIII treated polyurethane. Therefore the protein was almost washed from the 
untreated polyurethane. It shows that the protein on untreated polyurethane attached due to 
physical forces was disturbed by the physical forces of the detergent’s molecules. Washing in 
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detergent was sufficient to remove whole protein layers attached to the untreated surface due 
to physical forces.  
The amount of attached protein on PIII treated polyurethane after washing in detergent 
solution is lower than the amount of attached protein before the washing. However, a 
significant portion of the attached protein remains on the surface after washing despite the 
detergent’s physical forces. This shows that this protein is attached chemically to the surface. 
The ratio of attached to remained after detergent washing varies from 30% for 800 sec PIII 
treated sample to 95% for 400 sec PIII treated sample with average amount 63% for all PIII 
treated samples.  
 
4. Histology analysis of the tissue around the polyurethane implant 
The histological images of the sections stained with Milligan’ trichrome show that a collagen 
capsule is formed around all samples of the polyurethane implants (Figure 5). The 
polyurethane implants were removed at the microtome cutting due to very elastic 
polyurethane properties in comparison with the surrounding tissues. In all the images, the 
polyurethane was in the centre of the empty ovals. In some cases, the residuals of the 
polyurethane implants remained in the sections and stained slightly. The capsule 
continuously covers the implants, isolating the implant from the tissue. The observed 
ruptures in some capsules are due to the microtome cutting as shown by the character of the 
ruptures. The capsule for untreated polyurethane implants had more intensive colouring and 
was broader than for PIII modified implants. However, the capsule thickness appeared to be 
independent of what surrounded the implants, whether muscle or connectivity tissues.  
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Figure 5. Images of the histological samples of polyurethanes stained in Milligan. Objective 
x4. The implant position was in the centre of the ovals. Usually, the polyurethane sample was 
removed at the microtome cutting, but sometimes the small pieces of the polyurethane 
samples remain.  
The thickness of the capsule was analyzed quantitatively using the high resolution 
images of the tissue near the implants. The representative examples of the section stained 
with Milligan’ trichrome in high resolution for polyurethane implants with different PIII 
treatment times are presented in Figure 6.  
The collagen shell stained Milligan’s trichrome was well developed in the tissue 
surrounding the untreated polyurethane implants. The collagen fibres were structured and 
directed parallel to the implant surface on a distance of 40-60 µm. This part of the shell was 
characterised by dense collagen structure. The collagen fibres were disordered at a distance of 
60-120 µm from the implant surface. This part of the shell was less dense but denser than the 
collagen and elastin fibre structures in the normal tissue. In some samples the very dense 
collagen structure was observed in the first approximately 10 µm layer from the implant 
surface.  
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Figure 6. Microphotographs of the histological tissue samples stained in Milligan for 
untreated and PIII treated polyurethane. An empty space on the figures is the implant 
position.  
  The PIII treatment of the polyurethane implant changed the collagen shell in the 
organism (Figure 6). The dense collagen shell was not observed. The collagen shell near the 
implant surface was not developed and the collagen fibres were not directed but were 
disordered and rare. The whole collagen shell was thinner than for the untreated 
polyurethane implant. For some samples the shell was observed in 1-2 cell layers between the 
implant surface and the muscle cells. In some samples the dense collagen shell was observed 
in the thin surface layer (up to about 10 µm), which is in closest contact with the implant. All 
these difference in the collagen shell were observed in different animals and are not 
attributed to a specific immune reaction of one mouse.  
The average thickness of the collagen shell was calculated and is presented in Table 1. 
The staining of all the slides was done in one day, the microphotographs were done in one 
microscope in one day with adjusted intensity and optical elements of the microscope, and 
the analysis of the images was done for all microphotographs simultaneously. This allowed 
the results between the different samples in the whole batch to be compared quantitatively.  
The results show that the average thickness of the collagen capsule overall PIII treated 
samples was significantly less for the PIII treated polyurethane implants (41 µm) than for 
untreated implants (102 µm) (p<0.001). The significant decrease in the thickness from 102 µm 
to 46 µm was observed after a short 40 second PIII treatment time (p<0.01). This difference 
between the untreated and PIII treated samples increases with the PIII treatment time. The 
thinnest thickness (38 µm) is observed for 200 sec PIII treatment time.  
 
Table 1. Thickness (µm) of the capsule near the polyurethane implants in dependence on 
PIII treatment time.  
 Untreated 40 sec 80 sec 200 sec 400 sec 800 sec 
Thickness, µm 102±21 46±23 42±22 38±14 40±6 37±11 
 
The microphotographs of H&E stained tissue are shown in Figure 7. The tissue near the 
untreated polyurethane implant contains macrophages, monocytes and fibroblasts. Multi-
nuclear foreign body giant cells were not observed. The macrophages and monocytes were 
mostly distributed near the surface of the implant in the capsule. Their concentration was 
highest in the capsule near the implant surface. The fibroblasts were positioned mostly on a 
distance from the implant surface, where the collagen fibres dominate. There was no cell lysis 
or necrosis. 
The tissue near the PIII treated implant is less disturbed (Figure 7). Most cells in the 
capsule are fibroblasts and few cells were found in some spots like macrophages and 
monocytes (marked with arrows). The macrophages and monocytes were predominantly in 
the contact zone of the implant surface. In some images it is clear that the spots with 
macrophages and monocytes are distributed along the implant surface at the same 
periodicity as the cracks and waves of the polyurethane surface. Such cell distribution was 
observed for all PIII treatment times. Similar capsule images were observed in cases when the 
modified implant was in contact with the connective tissue or muscle tissue or adipocytes 
cells. In some places where the tissue contacted the modified implant the capsule was not 
observed at all. The cells, which were in contact with the implant surface, were fibroblasts or 
the connective tissue fibres. 
 
 
Untreated Polyurethane 
 
200 sec PIII treated polyurethane  
Figure 7. Microphotographs of the histological tissue samples stained in Hematoxylin-Eosin 
for the untreated and 200 sec PIII treated polyurethane implants. An empty space on the 
figures is the implant position. Positions of macrophages are shown with arrows. 
The staining with F4-80 antibody was used to detect a presence of macrophages in the 
tissue surrounding the polyurethane implants. The high macrophages activity was observed 
in the collagen capsule near the surface of the untreated polyurethane implant (Figure 8).  
The rest of the tissue outside of the collagen capsule showed low macrophages activity. 
The same low macrophages activity was observed in the tissue surrounding the PIII treated 
implant (Figure 8). For some samples macrophages activity near the implant surface was not 
observed.  
The integral area of the tissue with brown colour and the integral intensity of the colour 
was analysed to estimate the macrophages activity in the tissue. The results of activity 
macrophages dependence on the PIII treatment time are presented in Table 2. The highest 
macrophages activity was observed in the tissue surrounding the untreated polyurethane 
implant and 800 second PIII treated sample. The lowest macrophages activity was observed 
for 200 second PIII treated implants. The difference between the untreated and 200 second 
PIII treated samples is significant (p<0.001).  
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Figure 8. Microphotographs of the histological tissue samples stained in F4-80 antibody for 
the PPG-DI-PTHF-0.35 polyurethane implants. An empty space on the figures is the implant 
position.  
 
Table 2. Macrophages activity near the polyurethane implants in dependence on PIII 
treatment time.  
 Untreated 80 sec 200 sec 400 sec 800 sec 
Area, % 3.6±1.0 1.6±0.6 0.6±0.3 1.3±0.4 4.4±1.1 
Density, a.u. 9.8±2.7 4.0±1.4 1.7±0.8 3.4±1.1 13.7±4.0 
 
The Ki-67 antibody was used for detection of the cell proliferation activity in the tissue 
surrounding the polyurethane implants. The example of characteristic images for untreated 
and PIII treated implants with different PIII treatment time are presented in Figure 9. The 
colour distribution and intensity shows a high cell proliferation activity in the tissue near the 
untreated polyurethane implants. The maximum activity is observed in the collagen capsule 
and the activity gradually decreases with the distance from the implant.  
The cell proliferation activity near PIII treated implants was much less (Figure 8). In some 
samples the activity was observed only in a thin surface layer corresponding to the one cell 
thickness. Most intensive activity was observed in fields of new vessel formation.  
For a quantitative analysis of the cell proliferation activity the colour area and density of the 
Ki-67 staining was analysed and is presented in Table 3. The activity decreases with PIII 
treatment time and gets a minimal value at 400 seconds of the treatment time (p<0.001). This 
trend was observed in the area and the density of stained cells. 
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Figure 9. Microphotographs of the histological tissue samples stained in Ki-67 antibody for 
untreated and 80s PIII treated polyurethane. An empty space on the figures is the implant 
position.   
 
Table 3. Cell proliferation activity near the polyurethane implants in dependence on PIII 
treatment time.  
 Untreated 40 sec 80 sec 200 sec 400 sec 800 sec 
Area, % 1.12±0.37 0.88±0.26 0.51±0.30 0.47±0.25 0.32±0.11 0.37±0.23 
Density, a.u. 4.4±1.5 3.3±0.7 1.9±1.3 1.9±0.9 1.2±0.4 1.4±0.8 
 
Von Willebrand Factor (vWF) as a proinflammatory protein and a key player in hemostasis 
was analysed in the tissue surrounding the polyurethane implants. The microphotographs of 
the tissue stained in the vWF antibody are presented in Figure 10. The tissues near the 
untreated polyurethane implants accumulated a large amount of the vWF. Some samples 
show the highest concentration of the vWF in the capsule, but some samples show a 
distribution of the vWF in the whole tissue far from the capsule (an example on Figure 10). 
The vWF high amount was also observed in the new vessels. In PIII treated samples the vWF 
was concentrated in spots outside the capsule. Much lower amount vWF was observed in the 
tissue surrounding the PIII treated polyurethane implants. In some samples, the coloured 
area was not observed at all. In all these samples the capsule did not contain vWF.  
For quantitative measurements the area of vWF stained tissue was calculated (Table 4). The 
measurements show that the tissue near the implants of 80-800 s range of PIII treatment time 
has a significantly lower area of vWF than the tissue surrounding the untreated and 40 s PIII 
treated implants (p<0.001). The difference between the tissues near the PIII treated implants 
in 80 second - 800 second range was not significant (p>0.05).  
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Figure 10. Microphotographs of the histological tissue samples stained in Von Willebrand 
Factor for untreated and 80 sec PIII treated polyurethane. An empty space on the figures is 
the implant position. 
 
Table 4. Inflammatory activity near the polyurethane implants in dependence on PIII 
treatment time.  
 Untreated 40 sec 80 sec 200 sec 400 sec 800 sec 
Area, % 0.93±0.12 0.79±0.06 0.24±0.10 0.35±0.14 0.27±0.11 0.27±0.11 
 
5. Discussion 
Foreign Body Reaction (FBR) is a key problem for modern artificial implants [6]. It does not 
only limit the implant development but it limits the number of patients to whom the implants 
can be applied. An absence or reduction in the FBR would significantly improve the implant’s 
capacity to save life. However, despite how all modern implants satisfy physical and 
chemical stability, non-immunogenicity and non-toxicity requirements [16], all these implants 
still cause an immune response in an organism. This is why there is a widely held opinion 
that FBR cannot be avoided [5]: “All materials implanted into humans and animals elicit 
‘foreign body’ interactions, surrounding the materials with a protective capsule.” 
Attempts to avoid or decrease the immune reaction on artificial implants can be found in the 
literature [17-19]. All these attempts were based on stopping the immune reaction at some 
stage. For example, systemic corticosteroids decreases immune function and fibrosis, in 
particular it decreases the number of myofibroblasts [20]. However, our knowledge of the 
mechanism of the immune reaction is limited. The immune reaction is complicated and self-
regulated with multiple ways and steps. Blocking one step in the immune response will not 
prevent the protective capsule formation. 
Therefore, the most effective way to avoid the foreign body reaction is to do not ignite it. This 
way is used in the present study. 
The untreated polyurethane implant shows a minor foreign body reaction with formation of 
the capsule filled with macrophages and fibroblasts. The giant cells or necrosis were not 
observed in any samples. The thickness of the capsule of about 100 µm surrounding the 
implant corresponded to the literature data for biocompatible implants used in medical 
practice [4, 21]. Therefore, the untreated polyurethane corresponds to the biocompatible 
materials following the organism reaction.  
The organism response to PIII treated polyurethane was significantly reduced, showing that 
the average thickness of the capsule was significantly less near the treated polyurethane than 
near the untreated polyurethane. In some cases the capsule was not formed near the PIII 
treated polyurethane surface at all. In addition separate macrophages were observed on the 
surface with large distances between them whereas in other cases only normal tissue was 
observed. In some cases only one irregular layer of fibroblasts with thin not-structured 
collagen fibres was observed. 
Acute inflammation and capsule formation are usually observed 5-7 days after surgery. 
Chronic inflammation is observed following this period with a formation of thick isolating 
capsule around the implant. However, if the capsule around PIII treated polyurethane is not 
observed 7 days from the operation, it is possible that the capsule might be not formed later 
because a delayed formation of the capsule is less likely. Therefore, there are cases when the 
capsule is not formed or has significantly less thickness with a significantly lower amount of 
immune cells.  
For discussion of the histochemistry results this study considered a general scheme of 
immune reaction on an implant (Figure 1) [5] where the reaction is characterised by stages of 
the organism response, which becomes more complicated and intensive with time up to the 
total isolation of the implant from the body.  
The histochemistry results showed the significant difference in immune response of the mice 
organism on untreated and PIII treated polyurethane implants. At first, Von Willebrand 
Factor concentration in the tissue near the PIII treated implants differed from that near the 
untreated implants. The literature [22.] demonstrates that the Von Willebrand Factor is 
closely related to recruitment of the neutrophils in the injured tissue near the implant. When 
the Von Willebrand Factor concentration increases, the neutrophils are activated and 
collected in the injured tissue. The images of Von Willebrand Factor assay in the tissue near 
the untreated polyurethane implant correspond to a moderate immune reaction on the 
implants as seen in the literature [23, 24]. The lower Von Willebrand Factor concentration in 
the tissue near the PIII treated implant means that there is a less intensive inflammation and 
lower concentration and activity of neutrophils. Therefore the second stage has lower 
intensity for PIII treated implant than for the untreated implant.  
The macrophages are recruited at the next stage of the immune reaction. The role of 
macrophages is to remove the foreign body and/or to utilise the cell apoptosis products. The 
macrophages are recruited and activated via expression of cytokines released by neutrophils 
when the foreign body could not be destroyed in the body. The concentration and activity of 
the macrophages near the untreated implant show a moderate reaction of an organism 
consistent with the literature data [6, 25-27]. The lower concentration and activity of 
macrophages in the tissue near the PIII treated implant means that the macrophages are 
recruited and activated with much fewer signals from the neutrophils. Therefore the third 
stage of the immune response has a lower intensity.  
The new vessels formation and cell proliferation at the next stage provide a transport of 
immune cells to the injured tissue. These processes are ignited by released cytokines from the 
immune cells, which could not exclude the foreign body. At this stage the immune response 
includes deep transformation of surrounding tissues, which become involved into the healing 
process. The organism prepares to intensify the immune attack. The cell proliferation process 
in the tissue surrounding the untreated implant is much more intensive than in the tissue far 
away from the implant. The intensity at this stage is consistent with the literature on other 
implanted materials [6, 25-27]. However, the cell proliferation activity in the tissue 
surrounding PIII treated implant is much less. The cell proliferation is not detected, 
suggesting that the organism does not recognise the implant as a foreign body.  
With time the implant is encapsulated with collagen fibres. The fibroblasts are activated and 
build a cross-linked collagen capsule around the implant. At this stage the organism tries to 
isolate the foreign body from the tissues. The immune response is transformed to chronic 
inflammation. The thickness of the capsule depends on the intensity of the foreign body 
reaction. The capsule around the untreated polyurethane implant is about 100 µm, which 
corresponds to the moderate immune reaction for most of polymer implants [4, 21].  
The capsule surrounding the PIII treated implants is much thinner. This collagen capsule 
consists of rare disordered fibres whereas a capsule of dense ordered collagen fibres 
surrounds the untreated implant. In some cases the capsule near the PIII treated implant was 
not observed at all. Therefore, the host does not recognise the PIII treated implant as a foreign 
body, which must be isolated.  
All these observations are related to acute inflammation observed in the 7 days after the 
operation. According to the literature [4, 21], capsule thickness for untreated implants grown 
after the acute stage, increases during the chronic stage. In addition, previous long-term 
investigations with ion beam treated hard polyurethane showed the absence of immune 
response in the organism after 5-6 months. Because of this absence in these long-term 
experiments with the new polyurethane, we predict that the intensive chronic inflammatory 
reaction on PIII treated polyurethane is unlikely due to the low inflammatory reaction during 
the acute stage. Therefore, the low and absent foreign body reaction is achievable.  
 
 
 
Figure 11. Scheme of foreign body reaction with main stages from the time of first contact of 
the implant with organism tissue. The scheme is adapted from literature data [5] for PIII 
treated polyurethane. Red crosses show low or absent activity observed in the experiments 
with PIII treated implants. 
The thin capsule on ion beam treated implant is observed from the implant side [8]. The 
collagen capsule is well attached to the untreated polyurethane implant. However, the 
capsule is not found on ion beam implanted polyurethane surfaces with the carbonised top 
surface. The collagen structures are observed in the bottom of the crack of the carbonised 
layer, where the patches of untreated polyurethane are accessible by host proteins, 
phagocytes and fibroblasts.  
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A similar weak immune reaction was observed for ion beam treated polyurethanes in 
the experiments of Suzuki and colleagues [28]. Polyurethane samples treated by Ar+ were 
implanted into a rabbit for 16 days and a weak intensity of inflammatory reaction was 
observed. A similar effect of biocompatibility of polymer materials after the ion beam 
treatment was observed in vivo experiments with ePTFE grafts. ePTFE graft was treated by 
an ion beam and implanted in dogs’ femoral artery. The control sample showed thrombosis 
after 3 days, where the modified was clear after 180 days [29]. However, the mechanism 
responsible for the weak immune reaction was not discovered at that time.  
In the present study the attempt to prevent the phagocyte activation is based on the 
knowledge of specific adsorption of the host proteins on the PIII treated implant surface.  
It is clear now that the immune response of an organism starts from a specific adsorption 
of host proteins on the surface of the artificial implant [30]. Then the phagocytes recognise the 
adsorbed proteins on the implant surface and become activated. The activated phagocytes 
release specific cytokines, chemokines, interleukins and other factors, which ignite the next 
steps of the inflammation reaction. The activation of phagocytes is a complex process and 
includes local cytokine expression, transformation of the macrophages and giant cells. At 
some stage the fibroblasts are activated, proliferated and ignited to produce collagen to form 
a capsule around the implant.  
The host proteins in organisms exist in hydrophilic environment such as cytoplasm, 
extracellular liquids, blood and lymph. The biologically active conformation of the protein 
molecule is optimised for such an environment. When the host proteins come in contact with 
a surface of the artificial implant, the environment for the host proteins is changed: the 
protein is in contact with the implant, not with water molecules [31]. The protein molecule is 
adsorbed on the implant surface and changes the conformation due to different 
intermolecular interactions with the implant surface in comparison with the organism 
(hydrophilic) environment [26]. The conformation of absorbed protein depends on the 
surface properties [32]. However, all artificial implants have a surface energy in a range of 20-
45 MJ/m2 corresponding to the surface energy of the implant material [33]. This is much lower 
than the water surface energy of 72 MJ/m2. Therefore, the protein conformation changes to 
adjust the hydrophobic interactions with the implant.  
In contradiction with the untreated polyurethane, the PIII treated polyurethane implant 
is highly hydrophilic. The contact angle of the carbonised surface is 35-45 degrees for freshly 
treated polyurethane. The surface energy of the treated polyurethane 10 minutes after PIII 
treatment is 60-65 MJ/m2. Such a high surface energy and hydrophilicity is enough to absorb 
the water molecules and keep the hydrophilic intermolecular interactions with proteins in 
such a way that the protein is surrounded by water molecules and does not change the initial 
conformation at the point of absorption. This effect of hydrophilicity was observed for other 
polymers after PIII, ion beam treatment and plasma treatment [34]. For example, the 
literature shows a surface energy of 71 MJ/m2 for the freshly PIII treated Nylon [35] and 77.9 
MJ/m2 for the freshly treated polyvinyl chloride (PVC) [36]. It maintains the conformation of 
the absorbed protein and its activity. For example, the conformation of Horseradish 
peroxidase (HRP) attached to PIII treated polyethylene remains unchanged or close to the 
biologically active conformation as observed by Amide I line in the FTIR ATR spectra [37]. 
The enzyme activity of the HRP attached on PIII treated Teflon remains high [38].  
At the same time protein is attached covalently to the PIII treated polyurethane implant. 
The covalent attachment is key to the strong anchoring of the protein to the implant surface. 
The protein attachment to the untreated implant can be provided with different kinds of 
intermolecular interactions. The van-der-Waals forces, dispersic interactions, dipole-dipole 
interactions, ionic interactions or hydrogen bonds can hold the protein on the surface. 
However, these interactions are flexible and can be easily replaced with water-protein 
interactions. The more hydrophilic the surface, the easier the protein can be washed with 
detergent or just a buffer [39]. Such a weakness of the intermolecular interaction is a reason 
for the Vroman effect where the proteins can be easily replaced with other proteins in the 
protein mixture solutions or in an organism [31]. Such a flexibility of the protein adsorption 
can lead to unpredictable attachment of proteins, including signal proteins for igniting the 
immune reaction. 
The covalent attachment of protein is available with artificial chemical linkers [40-42]. 
The linker molecule is designed in such a way that one reactive group fixes the linker 
molecule on the surface and the second reactive group anchors the protein molecule to the 
linker. However, the chemistry of linker molecules is complicated. In most cases the linker 
molecules are toxic and cannot be used in an organism. Also the effectiveness of the linkers to 
bind the protein is much less than the total coverage. In such cases, part of the surface is not 
covered and the immune system can recognise the surface as foreign body.  
The PIII treated polyurethane surface can be covered completely. The protein monolayer 
forms a total coverage (carpet) on the PIII treated polymer surface [43] including 
polyurethane. The protein layer covalently attached to the PIII treated polyurethane implant 
is not washable. The protein molecules covalently attached to the PIII treated surface cannot 
be replaced with other proteins and the Vroman effect is not observed [44].  
The covalent attachment of protein on PIII treated polyurethane is provided via the 
reactions of free radicals which are formed when the polyurethane macromolecule is 
destroyed under high energy ion bombardment with formation of condensed aromatic 
structures like graphene or graphite. The free radicals are observed in the polyurethane 
implant after a long period of storage. The free radicals on the edges of the graphitic planes 
can be stabilised by π-electrons of the aromatic structure [9, 45] and remain active before the 
protein molecule approaches the modified surface. The literature shows that the reaction of 
free radicals appeared in polyethylene after ion beam treatment with aminoacids [46]. When 
the free radicals react with the protein molecule a covalent bond is formed [37]. As a result, 
the protein molecule bonds to the carbonised surface layer of the PIII treated polyurethane 
implant.  
The molecules with free radicals in solution are widely considered to accelerate aging of 
an organism because the host protein molecules can be damaged in free radical reactions [47]. 
The result of the protein damaging and oxidation can accelerate cell lysis and necrosis. These 
effects were not observed in surrounding implant tissue. The effect of free radicals on the 
protein requires the free radicals to be mobile in a solution. The free radicals in the 
polyurethane implant are associated with the condensed aromatic structures which are stable 
in polyurethane, and cannot propagate in the solution. When the protein is bonded with the 
surface, the protein does not migrate into the solution. The damaging of protein or decay of 
the protein activity was also not observed. Therefore, the free radicals in the polyurethane 
surface do not influence the organism’s tissues.  
The endothelialisation of the implant surface is one of the important factors of the 
biocompatibility [48]. Endothelialisation is considered a method of reducing the immune 
response [49]. The attachment of active protein can significantly improve cell adhesion [50]. A 
fast and total endothelialisation in an organism is the primary aim for the biocompatibility of 
implants. 
In the case of the newly synthesised polyurethane, the endothelial cells are spread and 
proliferate on the surface without PIII treatment. The endothelial cells also grow well on the 
PIII treated polyurethane surface. However, the untreated polyurethane is observed totally 
covered with the endothelial cells only after 6 days, while the PIII treated polyurethane is 
totally covered after 2 days as observed on the control tissue culture plastic (TCP) [51].  
Similar cell attachment and proliferation was observed for other ion beam and PIII 
treated polymers. For example, the ion beam treatment of polystyrene by Na and Ne ions of 
150 keV energy improved the endothelial cell spreading, attachment, proliferation and 
resistance to detaching with tripsin [52]. However, this research did not explain the 
mechanism by which this occurred. The adhesion and proliferation of endothelial cells and 
astrocytes on polyether sulphone and polyurethane by ion beam due to carbonisation of the 
polymer surface was reported in [53]. The endothelial cell adhesion and proliferation on PIII 
treated polyurethane was reported in [54]. The mechanism of improved cell adhesion via 
protein attachment due to free radical reactions was proposed in [10]. Thus, the attachment of 
protein with biologically active conformation leads to faster endothelialisation of the PIII 
treated polyurethane implant.  
 
The observed improvement of the polyurethane implant with PIII treatment can be 
considered for future soft tissue implants such as breast implants, testicular implants, 
cardiovascular implants, vascular grafts, diaphragms, finger joints, ear implants, nose 
implants and others. The mechanism for reducing the immune response based on free radical 
reaction is critical for successful implantation.  
First, the free radical concentration is reduced with time after PIII treatment. Therefore, 
the best result for implantation is expected when the implant is treated by plasma and 
installed immediately. Therefore, implants should be treated in an operating theatre just 
before surgery.  
Second, the free radicals are sensitive to any surface contamination after the PIII 
treatment. Specific environmental conditions and limited contact with any other materials 
and devices are required before implantation into an organism.  
Third, the sensitivity of free radicals limits sterilisation methods. Sterilisation by 
chemicals or gases reduces the concentration of free radicals and consequently the success of 
the implantation. Therefore, the sterilisation of the implant would be preferred before the PIII 
treatment. Taking into account that a plasma method is used for sterilisation [55], the PIII 
treatment can be done in sterile environments such as an operating theatre.  
In general, the potential of implants without FBR cannot be overestimated. 
Cardiovascular implants including heart valve, blood vessel, catheter, pacemaker and 
defibrillator which do not generate FBR can be applied without immunosuppressants. 
Patients would not be at a risk of infection after implantation. A category of patients, who are 
at risk of corresponding diseases and for whom the implantation has not been recommended, 
will be able to be treated with the implants. The risk of inflammation and thrombosis can be 
significantly reduced. The breast, lips and other cosmetic implants would not cause 
contracture. Implants with electrical connection to the tissue such as cochlear, spine 
neurostimulator, implantable brain stimulator, different sensors in organs and blood would 
never lose electrical conductivity through the fibrotic capsule in an organism (Fig.12). The 
implantable drug release devices would never lose the drug penetration rate through the 
fibrotic capsule. Only insulin permanent releasing devices will save millions of patients with 
diabetes.  Consequently, these improvements affect some millions of patients and can 
significantly influence our health, medical treatment and medical industry.  
 
 Figure 12. Scheme of implant with drug release or electrical connection. The foreign body 
reaction leads to an isolation of the implant with drug release or electrical signal. The drug 
release rate drops, the electrical current drops, the medical devise stops working (right 
image). The activated implant with the protein coverage keeps working: the drug release rate 
is stable; the electrical current is stable (left).  
 
5. Conclusions 
The investigations of the organism response on the untreated and PIII treated 
polyurethane implant show that all implants do not cause physiological dysfunctions in the 
mice. The PIII treated implants in mice show a weaker immune response of the organism, in 
particular: 
1. The capsule around the PIII treated implant is significantly thinner (p<0.01).  
2. The macrophages activity near the PIII treated implants is significantly weaker 
(p<0.001).  
3. The cell proliferation activity near the PIII treated implants is significantly weaker 
(p<0.001).  
4. The pro-inflammatory activity by vWF test is much weaker near the PIII treated 
implants (p<0.001).  
Therefore, the changes in the organism response on PIII treated implant in comparison 
with the untreated polyurethane implant are statistically significant.  
It was found that in some cases of the surface treated polyurethane the immune respond 
is neglectable. The reason of the low immune respond is covalent protein attachment on the 
implant surface. The protein attachment is provided by chemical reaction of the protein 
molecule with carbon atom with unpaired electron (free radical) on the edge of condensed 
aromatic structures with π-electron stabilizing cloud. The same unpaired electrons at the 
carbon atom on the surface are responsible for hydrophilic interaction with the attached 
protein providing saving protein conformation and activity.  
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Such implants with weak or without Foreign Body Reaction can potentially be applied 
without suppressor of immune system. We are looking for collaborators and funding to 
continue these studies.  
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